Journal article
The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies
Abstract
This post hoc analysis of the UNITI studies found ustekinumab (UST) did not significantly improve overall extraintestinal manifestations (EIMs) of Crohn's disease compared to placebo-treated patients at weeks 6 and 52.
BACKGROUND AND AIMS: The UNITI trials demonstrated that UST was effective in inducing and maintaining clinical remission in Crohn's disease (CD). However, limited data exists regarding its effectiveness for treatment of EIMs. …
Authors
Narula N; Aruljothy A; Wong ECL; Homenauth R; Alshahrani A; Marshall JK; Reinisch W
Journal
United European Gastroenterology Journal, Vol. 9, No. 5, pp. 581–589
Publisher
Wiley
Publication Date
6 2021
DOI
10.1002/ueg2.12094
ISSN
2050-6406